HBIO

8.6600.23%
SJ

Stephen J. DeNelsky

Independent Director

Mr. Stephen J. DeNelsky, also known as Steve, is Director of Harvard Bioscience, Inc. from September 5, 2025. He serves as Managing Director at Oaktree Specialty Lending Corp. since 2024. He serves as President of Life Sciences Alternative Funding LLC. Mr. DeNelsky was previously a Managing Director at Marathon Asset Management from 2019 to 2022. Mr. DeNelsky has been Senior Research Analyst of Copper Arch Capital, LLC since joining in March 2003. He has healthcare investment experience across all sectors including medical devices and diagnostics. Mr. DeNelsky served as the Portfolio Manager of Forstmann-Leff Associates LLC from November 2001 to March 2003. He Founded Sapphire Capital Management LLC, in December 2000 and served as its Managing Partner until November 2001. From June 1999 to December 2000, he served as a Senior Research Analyst of Credit Suisse First Boston's Health Care Equity Research Group, covering primarily the healthcare information technology and e-health sectors. From January 1996 to June 1999, Mr. DeNelsky served as Senior Research Analyst of Deutsche Banc Alex. Brown, ING Barings Furman Selz and McDonald & Company Securities. Prior to founding LSAF in 2013, Mr. DeNelsky worked for twelve years at various hedge funds as a healthcare analyst and portfolio manager. He served as Equity Analyst of Deutsche Bank AG, Research Division and Crédit Suisse First Boston, Inc., Research Division. Mr. DeNelsky was an Equity Analyst at Deutsche Bank Alex. Brown Inc., Research Division, ING Groep N.V., Research Division and KeyBanc Capital Markets Inc., Research Division. He served as Research Analyst of Crédit Suisse AG, Research Division. Mr. DeNelsky worked in the healthcare industry for a healthcare consulting, mergers and acquisitions and valuation firm based in Washington D.C. He was a Director of Samsara Vision, Inc. (Former Name: VisionCare Ophthalmic Technologies, Inc.) since October 2015 until May 2025 and previously served in the same role since October 2015 until 2020. He has been Lead Director of Merge Healthcare Solutions Inc. since 2005. and Director since March 2001. He served as Lead Director of Amicas (NASDAQ: AMCS) a healthcare technology company from 2001 to 2010. He has a BA in Economics from The American University and an MBA in International Finance from University of Maryland.

Positions